![]() |
Name |
5-Hydroxy-1,3-dimethyl-1,3-dihydro-2H-indol-2-one
|
Molecular Formula | C10H11NO2 | |
IUPAC Name* |
5-hydroxy-1,3-dimethyl-3H-indol-2-one
|
|
SMILES |
CC1C2=C(C=CC(=C2)O)N(C1=O)C
|
|
InChI |
InChI=1S/C10H11NO2/c1-6-8-5-7(12)3-4-9(8)11(2)10(6)13/h3-6,12H,1-2H3
|
|
InChIKey |
YQPARKFXCYFIBD-UHFFFAOYSA-N
|
|
Synonyms |
1010-68-0; 5-hydroxy-1,3-dimethyl-3H-indol-2-one; 5-Hydroxy-1,3-dimethyl-1,3-dihydro-2H-indol-2-one; 5-HYDROXY-1,3-DIMETHYL-2-INDOLINONE; 5-Hydroxy-1,3-dimethylindolin-2-one; 1,3-Dihydro-5-hydroxy-1,3-dimethyl-2H-indol-2-one; FOMBLINZ-15; SCHEMBL948429; 1,3-dimethyl-5-hydroxy-oxindole; DTXSID60344977; AKOS015909551; (+/-) 1,3-Dimethyl-5-hydroxy-oxindole; 010H680; AE-848/01470040; Indole-2-one, 2,3-dihydro-5-hydroxy-1,3-dimethyl-; 2H-Indol-2-one,1,3-dihydro-5-hydroxy-1,3-dimethyl-; 5-Hydroxy-1,3-dimethyl-1,3-dihydro-2H-indol-2-one #
|
|
CAS | 1010-68-0 | |
PubChem CID | 600894 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 177.2 | ALogp: | 1.2 |
HBD: | 1 | HBA: | 2 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 40.5 | Aromatic Rings: | 2 |
Heavy Atoms: | 13 | QED Weighted: | 0.658 |
Caco-2 Permeability: | -4.829 | MDCK Permeability: | 0.00001680 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.123 |
Human Intestinal Absorption (HIA): | 0.007 | 20% Bioavailability (F20%): | 0.025 |
30% Bioavailability (F30%): | 0.072 |
Blood-Brain-Barrier Penetration (BBB): | 0.336 | Plasma Protein Binding (PPB): | 91.20% |
Volume Distribution (VD): | 0.773 | Fu: | 4.87% |
CYP1A2-inhibitor: | 0.922 | CYP1A2-substrate: | 0.907 |
CYP2C19-inhibitor: | 0.07 | CYP2C19-substrate: | 0.231 |
CYP2C9-inhibitor: | 0.057 | CYP2C9-substrate: | 0.83 |
CYP2D6-inhibitor: | 0.16 | CYP2D6-substrate: | 0.865 |
CYP3A4-inhibitor: | 0.052 | CYP3A4-substrate: | 0.211 |
Clearance (CL): | 11.714 | Half-life (T1/2): | 0.874 |
hERG Blockers: | 0.006 | Human Hepatotoxicity (H-HT): | 0.18 |
Drug-inuced Liver Injury (DILI): | 0.102 | AMES Toxicity: | 0.396 |
Rat Oral Acute Toxicity: | 0.262 | Maximum Recommended Daily Dose: | 0.766 |
Skin Sensitization: | 0.492 | Carcinogencity: | 0.838 |
Eye Corrosion: | 0.161 | Eye Irritation: | 0.961 |
Respiratory Toxicity: | 0.351 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC006141 | ![]() |
0.392 | D04BNP | ![]() |
0.306 | ||
ENC006140 | ![]() |
0.377 | D0N0OU | ![]() |
0.298 | ||
ENC001539 | ![]() |
0.340 | D03XES | ![]() |
0.292 | ||
ENC005958 | ![]() |
0.339 | D00ZFP | ![]() |
0.278 | ||
ENC000344 | ![]() |
0.333 | D06BYV | ![]() |
0.276 | ||
ENC005475 | ![]() |
0.327 | D0YF3X | ![]() |
0.274 | ||
ENC001562 | ![]() |
0.327 | D0S5LH | ![]() |
0.264 | ||
ENC000501 | ![]() |
0.327 | D0S2BV | ![]() |
0.262 | ||
ENC002891 | ![]() |
0.321 | D0W6DG | ![]() |
0.257 | ||
ENC000500 | ![]() |
0.320 | D06GIP | ![]() |
0.255 |